Mid­dle-of-the-night NIH state­ment rais­es con­cerns on As­traZeneca's US vac­cine tri­al read­out

The NIH took the very un­usu­al step to re­lease a state­ment at mid­night, rais­ing fresh ques­tions about da­ta from As­traZeneca’s US-based Covid-19 vac­cine tri­al. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.